2009
|
Sign up to set email alerts
|

Abstract: The data validate the safety and efficacy of the investigational device, with a high clinical success rate and 12-month data indicating freedom from reintervention in the majority of patients treated.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
1

Year Published

2013
2013
2017
2017

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 76 publications
(40 citation statements)
references
References 13 publications
(15 reference statements)
0
39
1
Order By: Relevance
“…Observational data, however, noted a variable rate of stenting in the FP segment after excimer laser ranging from 23 to 50%, but these studies were not designed specifically to evaluate bailout stenting following laser treatment. [10][11][12] Altering vessel compliance may also be achieved by plaque modification without debulking of the lesion. For instance, cutting balloon (CB) atherotomes improve vessel compliance by scoring through a lesion, and therefore allowing better dilation of the vessel at lower balloon pressure.…”
mentioning
confidence: 99%
“…Observational data, however, noted a variable rate of stenting in the FP segment after excimer laser ranging from 23 to 50%, but these studies were not designed specifically to evaluate bailout stenting following laser treatment. [10][11][12] Altering vessel compliance may also be achieved by plaque modification without debulking of the lesion. For instance, cutting balloon (CB) atherotomes improve vessel compliance by scoring through a lesion, and therefore allowing better dilation of the vessel at lower balloon pressure.…”
mentioning
confidence: 99%
“…Although the CELLO study has used the Turbo-Booster laser guide catheter to increase lumen diameter and maximize plaque removal, the PP rate was 59% at 6 months and 54% at 1 year. TLR was required in 23.1% of CELLO participants at 1 year [16]. However, the mean lesion length in this study was relatively short (5.6 ± 4.7 cm).…”
Section: Discussionmentioning
confidence: 89%
“…Clinical trials of excimer laser have shown feasibility in treatment of both peripheral and coronary artery disease [15][16][17][18] .…”
Section: Discussionmentioning
confidence: 99%